| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A bis-boron boramino acid PET tracer for brain tumor diagnosis
|
Li, Zhu
|
|
|
51 |
6 |
p. 1703-1712
|
article
|
| 2 |
A comparison of [18F]AlF- and 68Ga-labeled dual targeting heterodimer FAPI-RGD in malignant tumor: preclinical evaluation and pilot clinical PET/CT imaging
|
Liu, Nan
|
|
|
51 |
6 |
p. 1685-1697
|
article
|
| 3 |
A comparison of visual assessment and semi-quantification for the diagnostic and prognostic use of [18F]flortaucipir PET in a memory clinic cohort
|
Mathoux, Gregory
|
|
|
51 |
6 |
p. 1639-1650
|
article
|
| 4 |
Amino acid PET vs. RANO MRI for prediction of overall survival in patients with recurrent high grade glioma under bevacizumab therapy
|
Chaban, Artem
|
|
|
51 |
6 |
p. 1698-1702
|
article
|
| 5 |
Anne G. Osborn, Luke L. Linscott, Karen L. Salzman: Osborn’s Brain: Imaging, Pathology and Anatomy, 3rd Edition
|
Mansi, Luigi
|
|
|
51 |
6 |
p. 1497
|
article
|
| 6 |
A rationally designed nuclei-targeting FAPI 04-based molecular probe with enhanced tumor uptake for PET/CT and fluorescence imaging
|
Zhao, Xingyang
|
|
|
51 |
6 |
p. 1593-1604
|
article
|
| 7 |
Brachytherapy at the nanoscale with protein functionalized and intrinsically radiolabeled [169Yb]Yb2O3 nanoseeds
|
Ghosh, Sanchita
|
|
|
51 |
6 |
p. 1558-1573
|
article
|
| 8 |
Challenges coexist with opportunities: development of a macrocyclic peptide PET radioligand for PD-L1
|
Huang, Wenpeng
|
|
|
51 |
6 |
p. 1574-1577
|
article
|
| 9 |
Combination of [18F]FDG and [18F]PSMA-1007 PET/CT predicts tumour aggressiveness at staging and biochemical failure postoperatively in patients with prostate cancer
|
Kim, Jisu
|
|
|
51 |
6 |
p. 1763-1772
|
article
|
| 10 |
Correction to: A bis-boron boramino acid PET tracer for brain tumor diagnosis
|
Li, Zhu
|
|
|
51 |
6 |
p. 1796-1797
|
article
|
| 11 |
Correction to: Positron emission tomography in the diagnosis and follow-up of transthyretin amyloid cardiomyopathy patients: A systematic review
|
Tingen, H. S. A.
|
|
|
51 |
6 |
p. 1798
|
article
|
| 12 |
Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy
|
Mansouri, Zahra
|
|
|
51 |
6 |
p. 1516-1529
|
article
|
| 13 |
Development of small-molecular-based radiotracers for PET imaging of PD-L1 expression and guiding the PD-L1 therapeutics
|
Yang, Hongzhang
|
|
|
51 |
6 |
p. 1582-1592
|
article
|
| 14 |
Downward myocardial creep during stress PET imaging is inversely associated with mortality
|
Kuronuma, Keiichiro
|
|
|
51 |
6 |
p. 1622-1631
|
article
|
| 15 |
False-positive [18F]FAPI-74 uptake caused by blood retention due to external jugular vein thrombus: Pitfall in the early-phase scan
|
Ohnishi, Akihito
|
|
|
51 |
6 |
p. 1790-1791
|
article
|
| 16 |
[18F]F-AlF-NOTA-octreotide PET/CT detected the [18F]FDG negative ectopic ACTH tumor in mediastinum
|
Chen, Lin
|
|
|
51 |
6 |
p. 1792-1793
|
article
|
| 17 |
2-[18F]FDG PET-based quantification of lymph node metabolic heterogeneity for predicting lymph node metastasis in patients with colorectal cancer
|
Xu, Lian
|
|
|
51 |
6 |
p. 1729-1740
|
article
|
| 18 |
First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients
|
Zhao, Ruiyue
|
|
|
51 |
6 |
p. 1753-1762
|
article
|
| 19 |
First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [68Ga]Ga-HER2 Affibody
|
Zhang, Mingru
|
|
|
51 |
6 |
p. 1713-1724
|
article
|
| 20 |
[18F]SynVesT-1 and [18F]FDG quantitative PET imaging in the presurgical evaluation of MRI-negative children with focal cortical dysplasia type II
|
Xiao, Ling
|
|
|
51 |
6 |
p. 1651-1661
|
article
|
| 21 |
[68 Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis
|
Unterrainer, Lena M.
|
|
|
51 |
6 |
p. 1786-1789
|
article
|
| 22 |
Guardians of precision: advancing radiation protection, safety, and quality systems in nuclear medicine
|
Giammarile, Francesco
|
|
|
51 |
6 |
p. 1498-1505
|
article
|
| 23 |
Impact on cardiovascular outcome of coronary revascularization-induced changes in ischemic perfusion defect and myocardial flow reserve
|
Assante, Roberta
|
|
|
51 |
6 |
p. 1612-1621
|
article
|
| 24 |
Initial results with [18F]FAPI-74 PET/CT in idiopathic pulmonary fibrosis
|
Mori, Yuriko
|
|
|
51 |
6 |
p. 1605-1611
|
article
|
| 25 |
MIDOS: a novel stochastic model towards a treatment planning system for microsphere dosimetry in liver tumors
|
Huesa-Berral, Carlos
|
|
|
51 |
6 |
p. 1506-1515
|
article
|
| 26 |
More than meets the eye: 2-[18F]FDG PET-based radiomics predicts lymph node metastasis in colorectal cancer patients to enable precision medicine
|
Huang, Wenpeng
|
|
|
51 |
6 |
p. 1725-1728
|
article
|
| 27 |
Neuronal intranuclear inclusion disease with cerebellar white matter tau uptake and incidental meningioma
|
Zhang, Yan
|
|
|
51 |
6 |
p. 1794-1795
|
article
|
| 28 |
On the rational use of thyroid scintigraphy in thyrotoxic patients in the age of integrated diagnostics
|
Campennì, Alfredo
|
|
|
51 |
6 |
p. 1682-1684
|
article
|
| 29 |
Peptidic heterodimer-based radiotracer targeting fibroblast activation protein and integrin αvβ3
|
Liu, Kehuang
|
|
|
51 |
6 |
p. 1544-1557
|
article
|
| 30 |
PET imaging of PD-L1 with a small molecule radiotracer
|
Zhao, Yajie
|
|
|
51 |
6 |
p. 1578-1581
|
article
|
| 31 |
Platelet-derived growth factor receptor β-targeted positron emission tomography imaging for the noninvasive monitoring of liver fibrosis
|
Li, Zhao
|
|
|
51 |
6 |
p. 1530-1543
|
article
|
| 32 |
Quantitative analysis of myocardial blood flow in surgically revascularized and not revascularized myocardial segments. A pilot PET study
|
Grandinetti, M.
|
|
|
51 |
6 |
p. 1632-1638
|
article
|
| 33 |
Surgical evidence-based comparison of [68Ga]Ga-FAPI-04 PET and MRI-DWI for assisting debulking surgery in ovarian cancer patients
|
Li, Xiang
|
|
|
51 |
6 |
p. 1773-1785
|
article
|
| 34 |
The accuracy and intra- and interobserver variability of PSMA PET/CT for the local staging of primary prostate cancer
|
Donswijk, Maarten L.
|
|
|
51 |
6 |
p. 1741-1752
|
article
|
| 35 |
The European Association of Nuclear Medicine (EANM)’s Response to the 2023 European Thyroid Association (ETA) clinical practice guidelines for thyroid nodule management and nuclear medicine: a deliberate oversight?
|
Kreissl, Michael C.
|
|
|
51 |
6 |
p. 1678-1681
|
article
|
| 36 |
The spatial extent of tauopathy on [18F]MK-6240 tau PET shows stronger association with cognitive performances than the standard uptake value ratio in Alzheimer’s disease
|
Gérard, Thomas
|
|
|
51 |
6 |
p. 1662-1674
|
article
|
| 37 |
Thyrotoxicosis is no insurance against thyroid cancer
|
Dizdarevic, Sabina
|
|
|
51 |
6 |
p. 1675-1677
|
article
|
Journal description